Skip to main content

Peer Review reports

From: Construction of a novel signature based on immune-related lncRNA to identify high and low risk pancreatic adenocarcinoma patients

Original Submission
29 Mar 2023 Submitted Original manuscript
29 Apr 2023 Reviewed Reviewer Report
7 May 2023 Reviewed Reviewer Report
25 May 2023 Reviewed Reviewer Report
18 Jun 2023 Author responded Author comments - Xiaoling Huang
Resubmission - Version 2
18 Jun 2023 Submitted Manuscript version 2
19 Jun 2023 Reviewed Reviewer Report
19 Jun 2023 Reviewed Reviewer Report
26 Jul 2023 Author responded Author comments - Xiaoling Huang
Resubmission - Version 3
26 Jul 2023 Submitted Manuscript version 3
27 Jul 2023 Reviewed Reviewer Report
27 Jul 2023 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
6 Aug 2023 Editorially accepted
14 Sep 2023 Article published 10.1186/s12876-023-02916-y

You can find further information about peer review here.

Back to article page